Logo
x

Search category

Subscribe Now

PANORAMA Trial

Regeneron Reports Results of Eylea (aflibercept) in P-III PANORAMA Trial for Diabetic Retinopathy (DR)

Regeneron Reports Results of Eylea (aflibercept) in P-III PANORAMA Trial for Diabetic Retinopathy (DR)

  • February 11, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.